The dose-response data show a weight effect that flattens toward the top of the range alongside dose-dependent gastrointestinal adverse events, which is consistent with a tolerability-driven choice but that reading is an inference drawn here, not a documented rationale, and Novo Nordisk has published no dose-selection statement
Here are some key reasons why consulting your healthcare provider is crucial before trying lipotropic injections: Personalized Assessment: Every individual's body is unique, and factors such as overall health, medical history, and existing conditions play a significant role in determining the suitability of any treatment, including lipotropic injections
At 5,000 mcg/mL, 250 mcg = 0.05 mL = 5 units
Goldwaser: The biggest risk is the unknown
An FDA advisory committee recommended BPC-157 for the Section 503A Bulks List in July 2026